USFDA has issued an Establishment Inspection Report (EIR) for Piramal Pharma Limited manufacturing facility located at Lexington (Kentucky, USA) and the inspection has now been successfully closed by the USFDA. On 11th January, 2023, the company talked about USFDA inspection at Piramal Pharma Limited’s manufacturing facility located at Lexington. 

 

Alembic Pharmaceuticals Limited has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection carried out by them at their Injectable Facility (F-3) at Karkhadi from 18-30th August, 2022. This was a pre-approval inspection for ANDAs filed with the USFDA. The company has already started receiving ANDA approvals manufactured at this facility.